Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Snowflake shares rallied significantly following strong quarterly financial results that exceeded analyst expectations, bolstered by accelerated demand for the company's AI coding tools. While the community is divided between bullish sentiment regarding the company's AI-driven growth and skepticism over its high valuation and ongoing losses, intense trading volume has triggered a sharp upward move that has squeezed short positions.

Broadcom shares faced volatility following a fiscal fourth-quarter revenue outlook that fell slightly short of high-end estimates, despite the company reporting strong third-quarter results with massive growth in AI semiconductor revenue. Investors remain divided, with many bullish traders citing the company's long-term AI growth guidance—including targets for significant revenue expansion through 2028—as a signal to buy the dip, while others express caution regarding customer concentration and execution risks.

Credo Technology Group is experiencing significant volatility and a sharp price decline following its latest quarterly report, with the community largely debating whether the move is an unjustified overreaction to concerns over margin compression and customer concentration, or a necessary correction of an overheated valuation. While many traders see the pullback as a long-term buying opportunity given the company's strong revenue growth and position in the AI infrastructure sector, others express concern over mounting bearish momentum and the potential for further downside.

Ultragenyx is trending following the failure of its late-stage clinical trial for the experimental Angelman syndrome drug apazunersen (GTX-102), which missed its primary and secondary endpoints. While some traders are expressing concern over the pipeline setback and potential for further downside, others are pointing to the company's established commercial portfolio and upcoming catalysts as reasons to remain long or accumulate shares.

Robinhood is trending as analysts issue bullish price target hikes, citing growth in the company's prediction markets, blockchain arm, and diversified product lines. While the community sentiment is split between bullish traders anticipating a breakout and skeptics debating market manipulation, the stock is seeing significant interest amid broader optimism in crypto-related assets.

Oracle is trending due to the expansion of its AI partnership with HPE to scale global data center infrastructure, sparking debate about the company's valuation and cloud growth potential ahead of its upcoming earnings report. While some investors remain cautious due to debt concerns and technical volatility, many point to its massive cloud backlog and AI infrastructure demand as catalysts for a potential rebound.

Algorand is receiving attention as traders debate the project's long-term potential, focusing on its recent v5.0 mainnet upgrade, post-quantum cryptography features, and ongoing institutional adoption. While some participants are accumulating tokens in anticipation of a market-wide altcoin rally and the potential passage of the Clarity Act, others express significant skepticism, citing ongoing token dilution and poor historical price performance.

Sarepta Therapeutics is experiencing significant buying pressure and volatility as investors look ahead to upcoming late-2026 clinical data readouts, specifically for its DM1 and FSHD programs. Traders are closely monitoring the company's recent leadership transition and the potential for a rebound in Elevidys revenue, while strong short interest continues to fuel speculation about a potential short squeeze or buyout.

HPE is trending following its fiscal third-quarter results, where the company reported a revenue and earnings beat while raising its full-year outlook. While retail traders are largely bullish, noting the company's value as an AI infrastructure play, shares faced pressure due to investor concerns regarding margin performance and persistent supply-chain constraints.

SoFi is facing downward pressure amid broader market concerns over rising Treasury yields and inflation, leading traders to debate its long-term growth thesis versus short-term institutional manipulation. While some investors see the pullback as a buying opportunity based on strong user and product growth, others are frustrated by the stock's lack of momentum and perceived underperformance relative to other fintech peers.